What is Project Alive?
Project Alive operates as a mission-driven non-profit organization focused on the eradication of Hunter syndrome, a rare genetic condition. The organization serves as a critical nexus between scientific research, patient advocacy, and community support. By providing a comprehensive ecosystem of resources for caregivers and healthcare professionals, Project Alive bridges the gap between clinical development and patient access. Its market position is defined by its unique ability to mobilize family-led initiatives to drive medical innovation, ensuring that curative medicine remains at the forefront of its operational agenda.
How much funding has Project Alive raised?
Project Alive has raised a total of $17K across 1 funding round:
Debt
$17K
Debt (2021): $17K with participation from PPP
Key Investors in Project Alive
PPP
Public-Private Partnership
What's next for Project Alive?
With the recent influx of capital, Project Alive is poised to transition into a more aggressive phase of research development. The strategic roadmap involves deepening partnerships with biotech laboratories and enhancing the infrastructure for clinical trials. As the organization matures, the focus will likely shift toward optimizing resource distribution and expanding its global advocacy network to ensure equitable access to emerging treatments. This growth phase is critical for translating laboratory successes into tangible patient outcomes, solidifying the organization's role as a leader in rare disease research.
See full Project Alive company page
